Clinical Observation of the Therapeutic Efficacy of Fuzi Lizhong Decoction Combined with SOX Regimen Chemotherapy in Treating Advanced Gastric Cancer with Spleen-Stomach Deficiency-Cold Syndrome
Not Applicable
Completed
- Conditions
- Gastric Cancer
- Registration Number
- ITMCTR2024000164
- Lead Sponsor
- Yichang Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The diagnostic criteria of Western medicine refer to the Guidelines for the Diagnosis and Treatment of Gastric Cancer (2022 Edition) by the Chinese Society of Clinical Oncology (CSCO) and the Guidelines for Holistic Integrative Management of Cancer (2022 Edition) by the Chinese Anti-Cancer Association (CACA).
Exclusion Criteria
Patients with other combined tumors; those with incomplete baseline data; those with psychological and/or mental disorders; those with ulcers, intestinal perforation, intestinal obstruction, or gastrointestinal bleeding; and those who are pregnant or breastfeeding.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CEA; IL-6;CA724;CA242;
- Secondary Outcome Measures
Name Time Method Clinical Efficacy;TCM Syndrome Scoring;Recent Therapeutic Effect;Karnofsky Performance Status Score;